This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1992 Jun;37(6):801-12.

doi: 10.1007/BF01300376.

Sulfasalazine. Multiplicity of action

T S Gaginella¹, R E Walsh

Affiliations

PMID: 1350243
DOI: 10.1007/BF01300376

Review

Sulfasalazine. Multiplicity of action

T S Gaginella et al. Dig Dis Sci. 1992 Jun.

. 1992 Jun;37(6):801-12.

doi: 10.1007/BF01300376.

Authors

T S Gaginella¹, R E Walsh

Affiliation

¹ Gastrointestinal Diseases Research, Searle Research and Development, Skokie, Illinois 60077.

PMID: 1350243
DOI: 10.1007/BF01300376

No abstract available

PubMed Disclaimer

Similar articles

Effects of sulfasalazine and a sulfasalazine analogue on the formation of lipoxygenase and cyclooxygenase products.
Tornhamre S, Edenius C, Smedegård G, Sjöquist B, Lindgren JA. Tornhamre S, et al. Eur J Pharmacol. 1989 Oct 10;169(2-3):225-34. doi: 10.1016/0014-2999(89)90019-8. Eur J Pharmacol. 1989. PMID: 2572437
Comparison of the effects of sulphasalazine, 5-aminosalicylic acid and sulphapyridine on the humoral response to antigen in vivo.
Sheldon P, Pell P. Sheldon P, et al. Adv Exp Med Biol. 1995;371B:905-8. Adv Exp Med Biol. 1995. PMID: 7502923 No abstract available.
Free radical scavenging reactions of sulfasalazine, 5-aminosalicylic acid and sulfapyridine: mechanistic aspects and antioxidant activity.
Joshi R, Kumar S, Unnikrishnan M, Mukherjee T. Joshi R, et al. Free Radic Res. 2005 Nov;39(11):1163-72. doi: 10.1080/10715760500177880. Free Radic Res. 2005. PMID: 16298742
Sulphasalazine, sulphapyridine or 5-aminosalicylic acid--which is the active moiety in rheumatoid arthritis?
Bird HA. Bird HA. Br J Rheumatol. 1995 Nov;34 Suppl 2:16-9. Br J Rheumatol. 1995. PMID: 8535642 Review.
5-Lipoxygenase inhibitors for the treatment of inflammatory bowel disease.
Rask-Madsen J, Bukhave K, Laursen LS, Lauritsen K. Rask-Madsen J, et al. Agents Actions. 1992;Spec No:C37-46. Agents Actions. 1992. PMID: 1359745 Review.

See all similar articles

Cited by

Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B.
Wahl C, Liptay S, Adler G, Schmid RM. Wahl C, et al. J Clin Invest. 1998 Mar 1;101(5):1163-74. doi: 10.1172/JCI992. J Clin Invest. 1998. PMID: 9486988 Free PMC article.
Biopharmaceutical considerations and characterizations in development of colon targeted dosage forms for inflammatory bowel disease.
Malayandi R, Kondamudi PK, Ruby PK, Aggarwal D. Malayandi R, et al. Drug Deliv Transl Res. 2014 Apr;4(2):187-202. doi: 10.1007/s13346-013-0185-4. Drug Deliv Transl Res. 2014. PMID: 25786732
Hyperbaric oxygen enhances the efficiency of 5-aminosalicylic acid in acetic acid-induced colitis in rats.
Gorgulu S, Yagci G, Kaymakcioglu N, Ozkara M, Kurt B, Ozcan A, Kaya O, Sadir S, Tufan T. Gorgulu S, et al. Dig Dis Sci. 2006 Mar;51(3):480-7. doi: 10.1007/s10620-006-3159-2. Dig Dis Sci. 2006. PMID: 16614956
Experience with the use of salazosulfapyridine for intractable diarrhea after hematopoietic stem cell transplantation.
Moriguchi N, Isokawa S, Ando A, Miyata H. Moriguchi N, et al. Int J Hematol. 2004 Dec;80(5):463-6. doi: 10.1532/ijh97.04089. Int J Hematol. 2004. PMID: 15646661
A Platform for the Development of Highly Red-Shifted Azobenzene-Based Optical Tools.
Lützel K, Laqua H, Sathian MB, Nißl B, Szántó JK, Senser CA, Savasci G, Allmendinger L, Kicin B, Ruf V, Kammerer D, Lohmüller T, Karaghiosoff K, Ali AM, Storch U, Mederos Y Schnitzler M, Ochsenfeld C, Konrad DB. Lützel K, et al. Angew Chem Int Ed Engl. 2025 Aug 4;64(32):e202501779. doi: 10.1002/anie.202501779. Epub 2025 Jun 23. Angew Chem Int Ed Engl. 2025. PMID: 40464072 Free PMC article.

See all "Cited by" articles

References

1. Clin Exp Immunol. 1978 Aug;33(2):217-24 - PubMed
1. Lancet. 1981 Aug 1;2(8240):255 - PubMed
1. Dig Dis Sci. 1989 Apr;34(4):573-8 - PubMed
1. Lancet. 1981 Dec 12;2(8259):1342-3 - PubMed
1. Gastroenterology. 1978 Oct;75(4):638-40 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database